Another study, using a transgenic mouse model containing the wild-type β-secretase site sequence of APP that is present in most AD patients, showed that cathepsin B gene deletion improves memory deficits and reduces brain amyloid plaque load [66]. Here, APP is linked to Alzheimer disease.